Clinical Trials Browser

Phase 2 × NETWORK × Advanced Rare Tumours × Clear all

NCT01396408 2025-03-18

A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

Phase 2 Active not recruiting

Advanced Rare Tumours

NCT02879162 2025-03-07

Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours

Phase 2 Completed

140 enrolled 9 charts

Advanced Rare Tumours